Ethrane
NDC Package 10019-350-50

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Ethrane is a . Marketed by Baxter Healthcare Corporation, this product is identified by NDC 10019-350 and is authorized under FDA application NDA017087.

Identification & Billing

NDC Package Code
10019-350-50
Package Description
125 mL in 1 BOTTLE
Product Code
10019-350
11-Digit Billing Format
10019035050

Clinical Specifications

Proprietary Name
Ethrane
Dosage Form
-

Regulatory & Marketing

Labeler Name
Baxter Healthcare Corporation
FDA Application #
NDA017087
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
08-28-1972
End Marketing Date
12-01-2012
Listing Expiration
12-01-2012
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (10019-350). Click a package code to view its specific billing and regulatory data.

10019-350-60
250 mL in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 10019-350-50 identifies a specific commercial package of 125 ml in 1 bottle of Ethrane, labeled by Baxter Healthcare Corporation. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Baxter Healthcare Corporation on August 28, 1972. The current certification is valid through December 01, 2012.

How is this Baxter Healthcare Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 10019035050. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
10019-350-50
11-Digit CMS (5-4-2)
10019-0350-50

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.